Gainers
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
Femasys Inc. (NASDAQ: FEMY) surged 244% to $1.1410 after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube.
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares gained 77.3% to $18.50. Alfasigma agreed to acquire Intercept Pharmaceuticals for $19.00 per share in cash.
Immunovant, Inc. (NASDAQ: IMVT) jumped 75.6% to $35.60 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
Tharimmune Inc (NASDAQ: THAR) shares gained 39.5% to $0.3090 after falling around 5% on Monday.
Acasti Pharma Inc. (NASDAQ: ACST) gained 27.1% to $2.2250. Acasti announced a $7.5 million private placement equity financing.
Cano Health, Inc. (NYSE: CANO) surged 24.2% to $0.3380. Cano Health said it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care.
Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) gained 23.6% to $3.5499. Bullfrog AI announced data from its preclinical study investigating the anti-cancer activity of a novel prodrug of mebendazole for glioblastoma.
Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 21.9% to $0.1987 after jumping over 36% on Monday. Avalo Therapeutics reported the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) shares climbed 21.2% to $6.16. Adaptive recently announced the launch ...
Benzinga
